<?xml version="1.0" encoding="UTF-8"?>
<p id="p0351" num="0351" sourceFile="EP 1326865B1.xml">The title compound was prepared using the procedure described in Example 86 replacing cyclopropylmethylamine with 1-(4-aminophenyl)-3-methylimidazolidin-2-one.
  <br/>
  <sup>1</sup>H NMR (CD30D, 400MHz) δ 9.07 (1H, d, 
  <i>J</i>=4.4Hz), 8.87 (1H, d, 
  <i>J</i>=8.4Hz), 7.80 (1H, dd, 
  <i>J</i>=4.4 and 8.4Hz), 7.53 (2H, d, 
  <i>J</i>=9.1Hz), 7.45 (2H, d, 9.1Hz), 7.38 (1H, d, 
  <i>J</i>=1.8Hz)), 7.35 (2H, d, 
  <i>J</i>=1.8Hz), 4.59 (2H, s), 3.84 (2H, m), 3.53 (2H, m) and 2.88 (3H, s)ppm.
  <br/> FAB MS calcd for C
  <sub>26</sub>H
  <sub>22</sub>Cl
  <sub>2</sub>N
  <sub>6</sub>O
  <sub>3</sub> 537.1 (MH
  <sup>+</sup>), found 537.1.
  <br/> FAB HRMS exact mass calcd for C
  <sub>26</sub>H
  <sub>22</sub>Cl
  <sub>2</sub>N
  <sub>6</sub>O
  <sub>3</sub> 537.1203 (MH
  <sup>+</sup>), found 537.1210.
</p>
